China’s ChiNext Index Rises Over 1% as STAR 50 Gains Nearly 2.8%

The divergence between the tech-heavy ChiNext and STAR 50 and the marginally lower Shanghai Composite points to a market still rewarding growth and innovation exposure over broader blue-chip benchmarks. The leadership of semiconductors, computing hardware and innovative drugs suggests capital is concentrating in policy-aligned sectors rather than rotating broadly. Whether that narrow leadership holds — or whether the breadth implied by nearly 3,100 advancing stocks can outlast the index-level gap — is the open question.